Comparison of DNA aneuploidy, chromosome 1 abnormalities, MYCN amplification and CD44 expression as prognostic factors in neuroblastoma.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  European Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0959-8049(95)00030-MPMID 7576963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Applied Sciences: Absence of CD44-standard in human neuroblastoma correlates with histological dedifferentiation, N-myc amplification and reduced survival probability.

  1994cited by this paper
• Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: results of the German Neuroblastoma Study Group.

  1994cited by this paper
• Multivariate evaluation of prognostic factors in localized neuroblastoma.

  1994cited by this paper
• Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment.

  1993cited by this paper
• Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.

  1993cited by this paper
• Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.

  1993cited by this paper
• Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.

  1993cited by this paper
• CD44--a new prognostic marker for neuroblastoma.

  1993cited by this paper
• Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

  1993cited by this paper
• Transcriptional activity of N-myc and ngf-R in 50 primary human neuroblastomas as predictor for clinical outcome.

  1993cited by this paper
• Clinical impact of chromosome I aberrations in neuroblastoma: A metaphase and interphase cytogenetic study

  1992cited by this paper
• Prognostic factors in metastatic neuroblastoma. A multivariate analysis of 182 cases.

  1992cited by this paper
• A significant association of Ha‐ras p21 in neuroblastoma cells with patient prognosis. A retrospective study of 103 cases

  1991cited by this paper
• P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma.

  1991cited by this paper
• Expression of the multidrug resistance, MDR1, gene in neuroblastomas.

  1990cited by this paper
• Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma.

  1990cited by this paper
• Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma.

  1988cited by this paper
• Prognostic factors in Neuroblastoma. Clinical, histopathologic, and immunohistochemical features and DNA ploidy in relation to prognosis

  1988cited by this paper
• Prognostic factors in neuroblastoma

  1987cited by this paper
• Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

  1985cited by this paper
• Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma.

  1984cited by this paper
• Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage.

  1984cited by this paper
• Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour

  1983cited by this paper
• Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines.

  1982cited by this paper
• Cytogenetic features of human neuroblastomas and cell lines.

  1981cited by this paper
• Regression models and life tables (with discussion

  1972cited by this paper

• Segmental chromosome aberrations as a prognostic factor of neuroblastoma: a meta-analysis and systematic review

  2024cites this paper
• Bronchial carcinoids

  2019cites this paper
• Neuroblastoma

  2018cites this paper
• INHIBITION MYCN- VERMITTELTER ZELLZYKLUSTRANSITION DURCH THYROID CANCER 1 (TC1) IM NEUROBLASTOM – ETABLIERUNG UND CHARAKTERISIERUNG DES TC1- ÜBEREXPRESSIONSPHÄNOTYPS IN HUMANEN SH-EP NEUROBLASTOMZELLEN UNTER DEM EINFLUSS VON MYCN

  2015cites this paper
• Immunohistochemical expression of CD44s in human neuroblastic tumors: Moroccan experience and highlights on current data

  2013cites this paper
• Impact of N-myc Amplification on Median Survival in Children With Neuroblastoma

  2012cites this paper
• Characteristics and outcome of patients with ganglioneuroblastoma, nodular subtype: a report from the INRG project.

  2012cites this paper
• Télomerase et destin des tumeurs neuroblastiques

  2010cites this paper
• Randomized Trial of prophylactic granulocyte colony-stimulating factor during rapid COJEC induction in pediatric patients with high-risk neuroblastoma: the European HR-NBL1/SIOPEN study.

  2010cites this paper
• Molecular Characteristics of Neuroblastoma with Special Reference to Novel Prognostic Factors and Diagnostic Applications

  2009cites this paper
• Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastoma

  2008cites this paper
• Comparison of different techniques for the detection of genetic risk-identifying chromosomal gains and losses in neuroblastoma

  2008cites this paper
• Expression of CD44 Is Associated with a Metastatic Pattern of Human Neuroblastoma Cells in a SCID Mouse Xenograft Model

  2008cites this paper
• Activity in Neuroblastoma

  2007cites this paper
• Genome-wide examination of chromosomal aberrations in neuroblastoma SH-SY5Y cells by array-based comparative genomic hybridization.

  2007cites this paper
• Patología de los tumores neuroblásticos: evaluación pronóstica. Experiencia del centro español de referencia de la SEOP para estudios biopatológicos del neuroblastoma (1992-2005)

  2007cites this paper
• Prognostic value of the International Neuroblastoma Pathology Classification in Neuroblastoma (Schwannian stroma-poor) and comparison with other prognostic factors: a study of 182 cases from the Spanish Neuroblastoma Registry

  2006cites this paper
• Perfil genómico del neuroblastoma de alto riesgo mediante hibridación genómica comparada

  2006cites this paper
• [Genomic profile in high risk neuroblastoma by comparative genomic hybridization].

  2006cites this paper
• The ip Deletion Is Not a Reliable Marker for the Prognosis of Patients with Neuroblastoma1

  2006cites this paper
• Characterization of karyotypic events and evolution in neuroblastoma

  2005cites this paper
• Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma.

  2004cites this paper
• Thorakales Neuroblastom bei einem jungen Erwachsenen

  2004cites this paper
• Hepatocyte Growth Factor/c-Met Signaling Promotes the Progression of Experimental Human Neuroblastomas

  2004cites this paper
• [Thoracic neuroblastoma in a young adult].

  2004cites this paper
• Clinical Aspects of Paediatric Urology

  2003cites this paper
• A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma.

  2003cites this paper
• Epidemiology and etiology of neuroblastoma: an overview.

  2003cites this paper
• Characteristics and Outcome of Thoracic Neuroblastoma

  2002cites this paper
• Proliferation marker KI‐S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification

  2002cites this paper
• Fluorescence in situ hybridization analyses of chromosome band 1p36 in neuroblastoma detect two classes of alterations

  2002cites this paper
• Cyclin D1-dependent regulation of B-myb activity in early stages of neuroblastoma differentiation

  2002cites this paper
• Characteristics and outcome of thoracic neuroblastoma.

  2002cites this paper
• Expression of Cell Adhesion Molecules, CD44s and E-Cadherin, and Microvessel Density in Carcinoid Tumors

  2002cites this paper
• Prognostic significance of DNA di-tetraploidy in neuroblastoma.

  2001cites this paper
• Dissertation for the Degree of Doctor of Philosopy (Faculty of Medicine) in Medicine presented at Uppsala University in 2001

  2001cites this paper
• Comprehensive genetic and histopathologic study reveals three types of neuroblastoma tumors.

  2001cites this paper
• Tumoren des Urogenitaltraktes im Kindesalter

  2001cites this paper
• Neuroblastoma tumour genetics: clinical and biological aspects.

  2001cites this paper
• Maligne viszerale Tumoren des Kindes

  2001cites this paper
• Neuroectodermal and neuroendocrine tumors principally seen in children.

  2001cites this paper
• Central neurocytomas are genetically distinct from oligodendrogliomas and neuroblastomas

  2000cites this paper
• Decreased survival in patients with CD44‐negative typical bronchial carcinoid tumors

  1999cites this paper
• Tumor vaccines--application to childhood cancer.

  1999cites this paper
• Expression of CD44 by rhabdomyosarcoma: a new prognostic marker?

  1999cites this paper
• Tumor vaccines - application to childhood cancer

  1999cites this paper
• Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system.

  1999cites this paper
• Clinical implications of anomalous CD44 gene expression in neoplasia.

  1998cites this paper
• The current contribution of molecular factors to risk estimation in neuroblastoma patients.

  1997cites this paper
• MYCN protein expression as a predictor of neuroblastoma prognosis.

  1997cites this paper
• Expression of CD44 isoforms in neuroblastoma cells is regulated by PI 3-kinase and protein kinase C

  1997cites this paper
• Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors.

  1997cites this paper
• Loss of chromosome 1p may have a prognostic value in localised neuroblastoma: results of the French NBL 90 Study. Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique (SFOP).

  1997cites this paper
• CD44: structure, function, and association with the malignant process.

  1997cites this paper
• Clinical significance of cytogenetic findings in solid tumors.

  1997cites this paper
• COMPARATIVE GENOMIC HYBRIDIZATION (CGH) ANALYSIS OF NEUROBLASTOMAS—AN IMPORTANT METHODOLOGICAL APPROACH IN PAEDIATRIC TUMOUR PATHOLOGY

  1997cites this paper
• N‐myc amplification and cell proliferation rate in human neuroblastoma

  1997cites this paper
• Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. U.K. Children's Cancer Study Group and the U.K. Cancer Cytogenetics Group.

  1997cites this paper
• Prognostic relevance of genetic alterations in the p32 region of chromosome 1 in neuroblastoma.

  1997cites this paper
• Prognostic significance of the proliferative activity in neuroblastoma.

  1997cites this paper
• Original Paper Gain of Chromosome Arm 17q Predicts Unfavourable Outcome in Neuroblastoma Patients

  1997cites this paper
• The CD44 proteins in embryonic development and in cancer.

  1996cites this paper
• CD44 isoform expression in the diffuse neuroendocrine system. II. Benign and malignant tumors

  1996cites this paper
• The recurrence patterns of stages I, II and III neuroblastoma: experience with 77 relapsing patients.

  1996cites this paper
• CD44 in malignant disorders.

  1996cites this paper
• Recent advances in the diagnosis, prognosis and classification of childhood solid tumours.

  1996cites this paper
• Expression of the gene for multidrug-resistance-associated protein and outcome in patients with neuroblastoma.

  1996cites this paper
• Genomic instability in Ip and human malignancies

  1996cites this paper
• CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer.

  1995cites this paper
• The 1p deletion is not a reliable marker for the prognosis of patients with neuroblastoma.

  1995cites this paper
• CD 44 IsoformsCorrelatewithCellularDifferentiationbutnotwithPrognosisin

  year unknowncites this paper